15 Small-Cap Healthcare Stocks Hedge Funds Are Buying

9. The Cooper Companies, Inc. (NASDAQ:COO)

No. of Hedge Fund Holders: 52

Market Capitalization: $16.49 Billion

Analyst Upside: 29.67%

Incorporated back in 1958, The Cooper Companies, Inc. (NASDAQ:COO) is a leading global medical device firm. The company operates through two units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry, while CooperSurgical deals with fertility and women’s healthcare.

The Cooper Companies, Inc. (NASDAQ:COO) is well on track to record another strong quarter. The company has surpassed earnings estimates in all four past quarters. However, the COO missed revenue in Q1 due to CooperSurgical’s seasonality. During Q2, the company is expected to post earnings of $0.92 per share, up by 9.5% from a year ago, driven by CooperVision’s daily lens growth and margin expansion. Analysts project the revenue to be around $995 million, up by almost 7.4% year-over-year. For the full year 2025, the company is anticipated to generate revenue between $4.08 billion and $4.16 billion, indicating 6-8% organic growth.

On the Street, COO stock sports a consensus Strong Buy rating. The average price target of $108.56 implies an upside of 33% from current levels.